Enrique A Conterno has sold stock and made no open-market buys since May 2017
CEO at Fibrogen Inc, and 1 other company
SEC CIK 0001476151 · Filings on SEC.gov ↗
$0Bought
$9.0MSold
NoneLast buy
Companies
Every filing
9 filings since May 2017, newest first
FGENSell
Fibrogen Inc
CEO
$152K−2.0%Jun 9
FGENSell
Fibrogen Inc
CEO
$36KApr 11
FGENSell
Fibrogen Inc
CEO
$394K−5.0%Mar 23
FGENSell
Fibrogen Inc
CEO
$1.2M−12.0%Mar 10
FGENSell
Fibrogen Inc
CEO
$31KJan 10
FGENSell
Fibrogen Inc
CEO
$40K−1.0%Dec 9
LLYSell
Lilly Eli & Co
SVP, Pres, LillyDiab, LillyUSA
$3.0M−15.0%Feb 20
LLYSell
Lilly Eli & Co
SVP, Pres, LillyDiab, LillyUSA
$2.1M−16.0%Jun 1
LLYSell
Lilly Eli & Co
SVP, Pres, LillyDiab, LillyUSA
$2.1M−17.0%May 8
Filings come from SEC EDGAR. Not investment advice.